Teva Pharmaceutical Industries (TEVA) Operating Income Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.28 Bn | 21.13 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.55 Bn | 12.12 Bn | 785.00 Mn | 21.25% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 350.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.63% |
| Dec 31, 2025 | 1,134.48% |
| Sep 30, 2025 | 1,829.41% |
| Jun 30, 2025 | 9,200.00% |
| Mar 31, 2025 | 338.07% |
| Dec 31, 2024 | -103.84% |
| Sep 30, 2024 | -114.83% |
| Jun 30, 2024 | 99.24% |
| Mar 31, 2024 | -1,576.92% |
| Dec 31, 2023 | 180.43% |
| Sep 30, 2023 | -18.87% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | 98.18% |
| Dec 31, 2022 | -1,305.13% |
| Sep 30, 2022 | -31.94% |
| Jun 30, 2022 | -266.15% |
| Mar 31, 2022 | -264.29% |
| Dec 31, 2021 | -80.79% |
| Sep 30, 2021 | 114.35% |
| Jun 30, 2021 | 236.42% |